Monitoring Blood Sugar to Support Safer Insulin Use in Older Adults
Tests a group education program using glucose monitors in older adults with type 2 diabetes.
Plain-language title generated from the registry record
Registry title: Safer Aging With Diabetes Monitoring
Key facts
- Where
- Fremont, Sacramento, San Jose, San Leandro, Santa Clara, and Union City, United StatesSee the 6 sites
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults aged 75 and older with type 2 diabetes who use insulin and have a higher risk of low blood sugar. It tests an education program that uses continuous glucose monitoring.
- Age
- 75 years and older
- Sex
- All sexes
- Disease stage
- Type 2 diabetes, with a higher risk of low blood sugar (hypoglycemia) in the past year, by self-report or use of health care
- Earlier treatment
- Must currently be treated with insulin. Must not have used a continuous glucose monitor (CGM) now or recently.
Main reasons for not taking part
- On renal dialysis
- Dementia
- Pacemaker or automatic implantable cardioverter defibrillator
- Using an insulin pump
- Severe mental illness, severe visual impairment, or in hospice
Read by machine on 9 November 2026.
Where in United States
- Kaiser Permanente-FremontFremont, United StatesNo longer taking part
- Kaiser Permanente - SacramentoSacramento, United StatesTaking people
- Kaiser Permanente San JoseSan Jose, United StatesNo longer taking part
- Kaiser Permanente San LeandroSan Leandro, United StatesNo longer taking part
- Kaiser Permanente Santa ClaraSanta Clara, United StatesNo longer taking part
- Kaiser Permanente - Union CityUnion City, United StatesNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Kaiser Permanente
- Trial code
- NCT06296485
- Record updated
- 4 August 2026
- Original description
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.Read full original descriptionShow less
Pragmatic Clinical Trial of Continuous Glucose Monitoring-based Interventions for Safe Insulin Use in High-Risk Older Adults With Type 2 Diabetes
Older adults with type 2 diabetes are at higher risk for severe hypoglycemia and its related complications (including hospitalization and death) when taking insulin. This study proposes to evaluate, in a randomized clinical trial, a strategy of safe insulin prescribing based on an educational program that leverages continuous glucose monitoring to support older adults at high risk for hypoglycemia. If the aims of this project are achieved, this novel care strategy could be widely applied to reduce severe hypoglycemia episodes in older, high-risk adults with type 2 diabetes.
Inclusion: Age 75 years and older; Diagnosis of Type 2 Diabetes; Current treatment with insulin; Increased hypoglycemia risk (prior year hypoglycemia by self-report or utilization); Able to communicate in English; Able to access email and the Internet.
Exclusion: Dementia; Severe Mental Illness; Severe Visual Impairment; On renal dialysis; Pacemaker or Automatic Implantable Cardioverter Defibrillator; Using insulin pump; In Hospice; Current or recent CGM use.